ARMS with PAX3/PAX7-FOXO1(together called PAX-FOXO1) gene fusion represents about 80% of ARMS cases (1, 4, 5), and the ones without fusion gene accounts for the rest 20%, which exhibit similar molecular patterns and clinical behaviors to ERMS. Here, FOXO1 is linked to alveolar rhabdomyosarcoma.